Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · first_quarter · 1A
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2010 · second_quarter · Q2
Source: Senate LDA
| NANOINK INC |
| 15 |
| 2007–2010 |
| ASTRAZENECA PHARMACEUTICALS LP | 14 | 2006–2010 |
| GENENTECH INC | 14 | 2007–2009 |
| MERCK | 13 | 2006–2010 |
| PARTNERSHIP TO IMPROVE PATIENT CARE | 9 | 2008–2010 |
| BIOGEN IDEC INC. | 8 | 2006–2008 |
| BRISTOL-MYERS SQUIBB | 8 | 2007–2009 |
| CUBIST PHARMACEUTICALS | 8 | 2006–2010 |
| EISAI CORPORATION OF NORTH AMERICA | 7 | 2009–2010 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 7 | 2009–2010 |
| SANOFI US SERVICES INC | 6 | 2009–2010 |
| ELI LILLY AND COMPANY | 4 | 2007–2008 |
| TETHYS BIOSCIENCE | 4 | 2007–2008 |
| ABBOTT LABORATORIES | 3 | 2007 |
| BECTON DICKINSON AND COMPANY | 3 | 2007–2008 |
| SANOFI-AVENTIS U.S. INC. | 3 | 2007–2008 |
| IMMUNEREGEN BIOSCIENCES INC | 2 | 2006–2007 |
| KLEINER PERKINS CAUFIELD & BYERS | 2 | 2006 |
| RESPIRONICS INC | 2 | 2006 |
| SUSAN G KOMEN FOR THE CURE | 2 | 2007 |
| PHARMATHENE, INC. | 1 | 2007 |
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
American Middle Class Tax (AMT) Relief Act of 2007
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: NANOINK INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMGEN · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: NANOINK INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act - S.369 Patent Reform Bill - S.515, H.R.1260
Patent Reform Bills- S. 515, H.R. 1260
Patent Reform S 515, HR 1260
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patent Reform Bills - S.515, H.R.1260 Preserve Access to Affordable Generics Act - S.369
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patent Reform Legislation- S 515; HR 1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515, H.R.1260
Patent Reform S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515, H.R.1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Patent Reform- S 515, HR 1260
Patent Reform- S 515, HR 1260
Patent Reform Bills- S. 515, H.R. 1260
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Patent Reform S 515, HR 1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Patent Reform Bills- S. 515, H.R. 1260; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act, S.369; Patent Reform - S.515, H.R.1260
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN · Firm: FOLEY HOAG LLP
Follow-on Biologics HR 1427, HR 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN · Firm: FOLEY HOAG LLP
Follow-on Biologics HR 1427, HR 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Follow-on Biologics -HR1427, HR 1548 FDA Globalization Act - HR 759
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Food and Drug legislation Safe-guarding America's Pharmaceutical Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN · Firm: FOLEY HOAG LLP
Follow-on Biologics H.R. 1427, H.R.154, S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid issues associated with the Patient Protection and Affordable Care Act of 2010, H.R. 3590 American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Medicare Coverage and Reimbursement Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES
NANOINK INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicaid Rebate Issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: Centers For Medicare and Medicaid Services (CMS)
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · second_quarter · Q2
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Biosilimars) Re-authorization of the Prescription Drug User Fee Act (No Bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid payment for Prescription drugs Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
Medicare Coverage and Reimbursement
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES
NANOINK INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coveraeg and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Medicaid Rebate Issues
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Medicare and Medicaid payment for Prescription drugs
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Medicare and Medicaid coverage and reimbursement issues
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · second_quarter · 2A
Follow-on Biologics H.R. 1427, H.R. 1548, S. 1695 Health care reform
ARRA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2@
Patent Reform Legislation - S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2@
Medicare Coverage and Reimbursement
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2@
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · 2@
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Anti-counterfeiting technology regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2@
Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
Patent Reform S 515, HR 1260
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3@
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · 3@
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · 4@
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2@
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
Medicare and Medicaid coverage and reimbursement issues
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Medicare and Medicaid coverage and reimbursement issues
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2A
Patent Reform Legislation - S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2A
Health Care Reform Follow-on Biologics
Medicare Coverage and Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2A
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Anti-counterfeiting technology regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Patent Reform S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Part B Medicare Reimbursement Medicare Improvements for Patients and Providers Act
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · second_quarter · 2A
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Patent Reform Bills- S. 515, H.R. 1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Preserve Access to Affordable Generics Act - S.369 Patent Reform Bill - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R. 3590; Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
Medicare Coverage and Reimbursement
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Safe-guarding America's Pharmaceuticals Act ; FDA Globalization Act - H.R.759; Medicare Improvement for Patients and Providers Act; FDA Amendments Act Implementation and Rulemaking Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Medicaid Rebate Issues; FDA Globalization Act - H.R.759 Pharmaceutical coverage and reimbursement issues associated with American Recovery and Reinvestment Act of 2009
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695.
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Medicare and Medicaid payment for Prescription drugs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Medicare and Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Preserve Access to Affordable Generics Act - S. 369 Patent Reform - S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patent Reform Bills - S.515, H.R.1260 Preserve Access to Affordable Generics Act - S.369
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
Patient Protection and Affordable Care Act - H.R.3590 Medicare coverage and reimbursement Medicaid Drug Rebate Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · 3A
Follow-on Biologics H.R. 1427, H.R.154, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · Q3
Follow-on Biologics H.R. 1427, H.R.154, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · third_quarter · Q3
Patent Reform Bills- S. 515, H.R. 1260; Preserve Access to Affordable Generics Act, S.369
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act- H.R. 3200
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Safe-guarding America's Pharmaceuticals Act FDA Globalization Act - H.R.759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicaid Rebate Issues FDA Globalization Act H.R.759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695.
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement issues
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · third_quarter · Q3
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2009 · third_quarter · Q3
Preserve Access to Affordable Generics Act, S.369; Patent Reform - S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Q3
Medicare Coverage and Reimbursement
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
ERSD payment
S.___ Affordable Healthy Choices Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics- H.R.1427, H.R.1548 Physician Payments Sunshine Act- S.301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · third_quarter · Q3
Preserve Access to Affordable Generics Act, S. 369. Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Americas Healthy Futures Act; Follow-on Biologics H.R. 1427, H.R.154, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Part B Medicare Reimbursement Medicare Improvements for Patients and Providers Act
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · second_quarter · Q2
ARRA
Follow-on Biologics H.R. 1427, H.R. 1548, S. 1695 Health care reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
Medicare Coverage and Reimbursement
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · Q2
Patent Reform Legislation - S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · Q2
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Anti-counterfeiting technology regulations
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · Q2
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · second_quarter · Q2
Patent Reform Bills- S. 515, H.R. 1260
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Patent Reform S 515, HR 1260
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2009 · second_quarter · Q2
FDA Reform Bills
Pharmaceutical coverage and reimbursement issues associated with American Recovery and Reinvestment Act of 2009
S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · second_quarter · Q2
Pharmaceutical coverage and reimbursement issues associated with American Recovery and Reinvestment Act of 2009
S. 1213, The Patient-Centered Outcomes Research Act H.R. 2502, The Comparative Effectiveness Research Act
Patent Reform- S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · first_quarter · Q1
Compartive Effectiveness Research. American Recovery and Reinvestment Act of 2009- HR 1
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · first_quarter · Q1
Health Reform; Patent Reform; Follow-on Biologics; Compartive Effectiveness Research
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2009 · first_quarter · Q1
Kennedy Cancer Bill- S 717
Medicare Coverage and Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 515, The Patent Reform Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE